Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wander

Showing results (1081-1090 of 1,099) with videos related to

Pageof 110
Sort By:
The Journal of the Association of Physicians of India|April 9, 2025
Optimizing Screening Strategies for Hypertension in India: A Consensus StatementJagdish S Hiremath, Gurpreet S Wander, Arup Dasbiswas, et al.
Indian Heart Journal|May 25, 2023
COVID-19 infected ST-Elevation myocardial infarction in India (COSTA INDIA)Abdullakutty Jabir, Geevar Zachariah, Padinhare Purayil Mohanan, et al.
Journal of Clinical Lipidology|March 14, 2024
Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IVRaman Puri, Manish Bansal, Vimal Mehta, et al.
Indian Heart Journal|August 10, 2020
Cardiological society of India document on safety measure during echo evaluation of cardiovascular disease in the time of COVID-19Rakesh Gupta, Mrinal Kanti Das, P P Mohanan, et al.
The Journal of the Association of Physicians of India|May 13, 2024
The Promise of Cilnidipine in Hypertension with Comorbidities: National Consensus Statement: National Consensus Group Comprises Cardiologists, Nephrologists, and Diabetologists from India in a National Meet at New Delhi held on 22<sup>nd</sup> May 2022Hirday Kumar Chopra, Gurpreet S Wander, Chandrashekhar K Ponde, et al.
The Journal of the Association of Physicians of India|June 24, 2023
The Power and Promise of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in Heart Failure Management: National Consensus StatementH K Chopra, G S Wander, C K Ponde, et al.
Science Translational Medicine|October 5, 2021
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal modelsBert Schepens, Loes van Schie, Wim Nerinckx, et al.
The Journal of the Association of Physicians of India|June 17, 2024
Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney DiseaseH K Chopra, Dinesh Khullar, Tiny Nair, et al.
Indian Heart Journal|August 31, 2023
Impact of COVID-19 on heart failure hospitalization and outcome in India - A cardiological society of India study (CSI-HF in COVID 19 times study - "The COVID C-HF study")Jayagopal P B, Ramakrishnan S, Mohanan P P, et al.
The Journal of the Association of Physicians of India|May 13, 2024
Role of Bisoprolol in Heart Failure Management: A Consensus Statement from IndiaH K Chopra, Tiny Nair, G S Wander, et al.
Pageof 110

Showing results (1081-1090 of 1,099) with videos related to

Sort By:
Pageof 110
The Journal of the Association of Physicians of India|April 9, 2025
Optimizing Screening Strategies for Hypertension in India: A Consensus StatementJagdish S Hiremath, Gurpreet S Wander, Arup Dasbiswas, et al.
Indian Heart Journal|May 25, 2023
COVID-19 infected ST-Elevation myocardial infarction in India (COSTA INDIA)Abdullakutty Jabir, Geevar Zachariah, Padinhare Purayil Mohanan, et al.
Journal of Clinical Lipidology|March 14, 2024
Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IVRaman Puri, Manish Bansal, Vimal Mehta, et al.
Indian Heart Journal|August 10, 2020
Cardiological society of India document on safety measure during echo evaluation of cardiovascular disease in the time of COVID-19Rakesh Gupta, Mrinal Kanti Das, P P Mohanan, et al.
The Journal of the Association of Physicians of India|May 13, 2024
The Promise of Cilnidipine in Hypertension with Comorbidities: National Consensus Statement: National Consensus Group Comprises Cardiologists, Nephrologists, and Diabetologists from India in a National Meet at New Delhi held on 22<sup>nd</sup> May 2022Hirday Kumar Chopra, Gurpreet S Wander, Chandrashekhar K Ponde, et al.
The Journal of the Association of Physicians of India|June 24, 2023
The Power and Promise of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in Heart Failure Management: National Consensus StatementH K Chopra, G S Wander, C K Ponde, et al.
Science Translational Medicine|October 5, 2021
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal modelsBert Schepens, Loes van Schie, Wim Nerinckx, et al.
The Journal of the Association of Physicians of India|June 17, 2024
Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney DiseaseH K Chopra, Dinesh Khullar, Tiny Nair, et al.
Indian Heart Journal|August 31, 2023
Impact of COVID-19 on heart failure hospitalization and outcome in India - A cardiological society of India study (CSI-HF in COVID 19 times study - "The COVID C-HF study")Jayagopal P B, Ramakrishnan S, Mohanan P P, et al.
The Journal of the Association of Physicians of India|May 13, 2024
Role of Bisoprolol in Heart Failure Management: A Consensus Statement from IndiaH K Chopra, Tiny Nair, G S Wander, et al.
Pageof 110